Liquid chromatography–tandem mass spectrometry (LC–MS/MS) reveals distinct sphingolipid patterns in anorexia and obesity.
|Articles|July 29, 2022
- August 2022
- Volume 18
- Issue 8
Vol 18 No 8 The Column August 2022 Europe & Asia PDF
Advertisement
Click the image below to open The Column August 2022 Europe & Asia issue, Volume 18, Number 8, in an interactive PDF format.
Articles in this issue
over 4 years ago
Trends and Developments in Gas Chromatographyover 4 years ago
ISC 2022 Previewover 4 years ago
Rising Stars of Separation Science: Natalia Manousiover 4 years ago
Tips & Tricks: Column Order in GPC/SECover 4 years ago
Miniaturized Nano-HPLC–ESI-IMS System for Water Analysisover 4 years ago
Knauer Celebrates 60 Glorious YearsAdvertisement
Related to this article
Leon Niezen and Gert Desmet discuss uncertainty-driven LC method development, peak overlap, and moving from in silico to real data.
Leon Niezen and Gert Desmet describe how predictive uncertainty can make automated LC method development more reliable.
Liquid chromatography–mass spectrometry (LC–MS) serum profiling ties lysine compounds to lupus kidney disease.
Liquid chromatography-mass spectrometry (LC–MS) growth lifts Waters Q3; MOBILion ion mobility buy expands proteomics.
Liquid chromatography–tandem mass spectrometry (LC–MS/MS) measures galactose-1-phosphate in dried blood spots to monitor galactosemia.
Sam Whitmarsh explores how retention-time models handle interlaboratory data, novel chemotypes, unusual phases and ionisable compounds, and what labs need to do to build useful in-house models.
Advertisement
Advertisement
Trending on LCGC International
1
AI/ML Now: Toxicity Prediction for Unknown LC–HRMS Features Using Machine Learning
2
LCGC Blog: Building a Career Series That Goes Beyond the Surface
3
From 9000 Clues to a Clinical Test: Mass Spectrometry-Driven Lipidomics for Early Cancer Detection
4
Industry Roundup: Waters Posts Strong Third Quarter as LC–MS and Chromatography Consumables Drive Growth, Acquires Ion Mobility Pioneer MOBILion
5